September 24, 2016 11:29 PM ET

Life Sciences Tools and Services

Company Overview of BioNano Genomics, Inc.

Company Overview

BioNano Genomics, Inc. operates as a genome mapping company. The company develops Irys, a flexible platform capable of providing single-molecule analysis of extremely long DNA. Its platform provides researchers and clinicians an organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. The company’s Irys system includes IrysPrep reagent kits that supplement readily available enzymes with other enzymes, dyes, and buffers needed to label non-amplified DNA for the Irys system; IrysChips for sample handling of precious or minute samples in a convenient 2-flowcell format; Irys Instrum...

9640 Towne Centre Drive

Suite 100

San Diego, CA 92121

United States

Founded in 2003





Key Executives for BioNano Genomics, Inc.

Chief Executive Officer, President and Director
Age: 48
Founder and Chief Scientific Officer
Vice President of Finance
Chief Commercial Officer
Age: 46
Vice President of Corporate Development
Age: 44
Compensation as of Fiscal Year 2016.

BioNano Genomics, Inc. Key Developments

BioNano Genomics, Inc. Announces Executive Changes

BioNano Genomics announced that it has elected David Barker, Ph.D., former Chief Scientific Officer of Illumina, as Chairman of the Board. BioNano has further strengthened its executive management team with two additional appointments: Sean Paolino to Vice President, Finance and Warren Robinson to Vice President, Global Sales and Marketing.

BioNano Genomics and Berry Genomics Co., Ltd. to Co-Develop Next-Generation Mapping System for Chinese Food and Drug Administration-Approved Clinical Use in China

Berry Genomics Co., Ltd. announced that it has chosen BioNano Genomics' Irys system for next-generation mapping (NGM) as the platform on which Berry will seek Chinese Food and Drug Administration (CFDA) regulatory approval for a number of clinical indications in China. Under the agreement, the companies will co-develop an NGM system to provide cost-effective, easy-to-use assays for detection of chromosomal structural variations. The new assays and instrument system are to be validated in clinical settings in China and submitted for review under the CFDA's medical device registration process. The system will integrate proprietary assays designed by BioNano and Berry with a next-generation mapping instrument based on BioNano's Irys platform. Berry will exclusively manufacture and market the system and assays in China for clinical use in selected indications. BioNano will continue to market its Irys system in China to the rest of the research community, including genomics centers, governmental and academic institutions, translational research facilities and pharmaceutical companies.

BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-10-2016 06:15 PM

BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-10-2016 06:15 PM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: R. Erik Holmlin, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioNano Genomics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at